Literature DB >> 10425407

Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results.

S Michopoulos1, P Tsibouris, H Bouzakis, M Sotiropoulou, N Kralios.   

Abstract

BACKGROUND: Barrett's esophagus is a premalignant condition. It has been reported that several methods of endoscopic ablation in combination with acid suppression result in replacement of specialized columnar epithelium by squamous epithelium. The aim of this study was to assess whether ablation of Barrett's mucosa by means of heat probe and acid suppression restores normal esophageal mucosa.
METHODS: Thirteen patients with Barrett's epithelium but not dysplasia were enrolled in the study. Helicobacter pylori was eradicated when discovered. Thermal energy was applied using a heat probe (pulses of 5 to 10 joules). Four-quadrant biopsies were obtained at 1 to 2 cm intervals 1 to 3 months after the last treatment session. All patients continuously took omeprazole, 40 mg/day.
RESULTS: Macroscopically, ablation of Barrett's mucosa was achieved in all patients after 1 to 5 sessions. Three of the 13 patients had residual specialized columnar epithelium beneath the restored mucosa but not overexpression of p53 and c-erbB-2. During follow-up (6 to 36 months) two patients in whom the length of Barrett's mucosa was greater than 2.5 cm relapsed after omeprazole discontinuation, whereas another two with length of less than 2.5 cm did not. One patient with residual Barrett's islands developed low-grade dysplasia.
CONCLUSIONS: Heat probe is an effective and inexpensive method for Barrett's ablation. Islands of residual specialized columnar epithelium were found in 23% of patients. The length of Barrett's epithelium determines relapse after omeprazole discontinuation. (Gastrointest Endosc 1999;50:165-72).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425407     DOI: 10.1016/s0016-5107(99)70219-1

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  6 in total

1.  [Barrett esophagus: ablative methods of treatment].

Authors:  M Jung; C Ell
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

Review 2.  Prevention of adenocarcinoma by reversing Barrett's esophagus with mucosal ablation.

Authors:  Richard E Sampliner
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

3.  Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus.

Authors:  Katerina Dvorak; Lois Ramsey; Claire M Payne; Richard Sampliner; Ronnie Fass; Harris Bernstein; Anil Prasad; Harinder Garewal
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

4.  Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus.

Authors:  Rami J Badreddine; Ganapathy A Prasad; Kenneth K Wang; Louis M Wong Kee Song; Navtej S Buttar; Kelly T Dunagan; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Gastrointest Endosc       Date:  2009-12-03       Impact factor: 9.427

5.  Cleavage of E-Cadherin Contributes to Defective Barrier Function in Neosquamous Epithelium.

Authors:  Thomas M Runge; Nicholas J Shaheen; Zorka Djukic; Suzanne Hallquist; Roy C Orlando
Journal:  Dig Dis Sci       Date:  2016-09-22       Impact factor: 3.199

Review 6.  Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy.

Authors:  Devidas Menon; Tania Stafinski; Heng Wu; Darren Lau; Clarence Wong
Journal:  BMC Gastroenterol       Date:  2010-09-27       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.